Team:RMIT Australia/Team
From 2010.igem.org
(Difference between revisions)
(→Areas Divided:) |
(→Instructors:) |
||
(2 intermediate revisions not shown) | |||
Line 416: | Line 416: | ||
*''' Leonard Pattenden''' | *''' Leonard Pattenden''' | ||
*''' Brett Cromer''' | *''' Brett Cromer''' | ||
- | *''' Florencia Camus | + | *''' Florencia Camus''' |
- | + | ||
===Advisors=== | ===Advisors=== | ||
Line 432: | Line 431: | ||
*'''Danni Kamato''': This is my second year in iGEM, really enjoyed the challenge and experience last year, loved working in the lab on something I'm interested in and can't wait to do it over this year. | *'''Danni Kamato''': This is my second year in iGEM, really enjoyed the challenge and experience last year, loved working in the lab on something I'm interested in and can't wait to do it over this year. | ||
*'''Tirath Singh''': Currently studying Pharmaceutical Science at RMIT; first time participant in the iGEM project. I am interested in the application of potential genetic therapies in combating disease, in combination with traditional Pharmaceutical therapies and how new developments in synthetic biology can combine these two areas. | *'''Tirath Singh''': Currently studying Pharmaceutical Science at RMIT; first time participant in the iGEM project. I am interested in the application of potential genetic therapies in combating disease, in combination with traditional Pharmaceutical therapies and how new developments in synthetic biology can combine these two areas. | ||
- | *'''Karen Lee''': | + | *'''Karen Lee''': I am a new member of the iGEM team and it has been very interesting and informative for me. My interest is in toxins from snakes, spiders , plants and any other forms that have chemicals that can potentially be used in medicine .Another interest of mine includes microorganisms and our capability to manipulate their characteristics genetically.iGEM has provided me an opportunity to gain an insight into genetic manipulation techniques. |
*'''Hiwot Kelemwork''': this is my first year doing iGEM, i am exited to be part of this great expierence and have gained a great deal of knoweledge through my participation. i am currently in my 3rd year of biomedical science. | *'''Hiwot Kelemwork''': this is my first year doing iGEM, i am exited to be part of this great expierence and have gained a great deal of knoweledge through my participation. i am currently in my 3rd year of biomedical science. | ||
Line 447: | Line 446: | ||
</a> | </a> | ||
</html> | </html> | ||
- | |||
- | |||
===Areas Divided:=== | ===Areas Divided:=== | ||
*'''Ebony Perkins''': Safety aspects, wiki | *'''Ebony Perkins''': Safety aspects, wiki | ||
- | *'''Sebastian Ramov''': Ligation independent aspects of the project, survey collaboration, wiki | + | *'''Sebastian Ramov''': Ligation independent aspects of the project, survey collaboration, wiki, ordering |
- | *'''Michelle Chayeb''': sponsorship, carrier proteins, survey collaboration, peptide - vasopressin, wiki | + | *'''Michelle Chayeb''': sponsorship, carrier proteins, survey collaboration, peptide - vasopressin, wiki, poster |
- | *'''Danni Kamato''': Taq mutations/modelling, survey collaboration, wiki | + | *'''Danni Kamato''': Taq mutations/modelling, survey collaboration, wiki, poster |
*'''Tirath Singh''':Taq mutation/modelling, wiki | *'''Tirath Singh''':Taq mutation/modelling, wiki | ||
*'''Karen Lee''': Survey collaboration, peptide - Losartan, wiki | *'''Karen Lee''': Survey collaboration, peptide - Losartan, wiki |
Latest revision as of 12:00, 27 October 2010